EUVIMEDEUVIMED entdecken
Crossref

From ‘lipopolysaccharide as a biomarker’ to implementation-ready endotoxemia phenotyping in diabetes: Clarifications and a minimal translation pipeline

Mulavagili Vijayasimha, M. Srikanth

Indian Journal of Physiology and Pharmacology · 11.07.2026 · 1-2

DOI: 10.25259/ijpp_10_2026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Physiology and Pharmacology, online erschienen am 11.07.2026. Verfasst von Mulavagili Vijayasimha und 1 weiteren Autor:innen. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Vijayasimha, M., & Srikanth, M. (2026). From ‘lipopolysaccharide as a biomarker’ to implementation-ready endotoxemia phenotyping in diabetes: Clarifications and a minimal translation pipeline. Indian Journal of Physiology and Pharmacology, 0, 1-2. https://doi.org/10.25259/ijpp_10_2026

Vancouver

Vijayasimha M, Srikanth M. From ‘lipopolysaccharide as a biomarker’ to implementation-ready endotoxemia phenotyping in diabetes: Clarifications and a minimal translation pipeline. Indian Journal of Physiology and Pharmacology. 2026;0:1-2. doi:10.25259/ijpp_10_2026

BibTeX
@article{Vijayasimha2026,
  author = {Vijayasimha, Mulavagili and Srikanth, M.},
  title = {From ‘lipopolysaccharide as a biomarker’ to implementation-ready endotoxemia phenotyping in diabetes: Clarifications and a minimal translation pipeline},
  journal = {Indian Journal of Physiology and Pharmacology},
  year = {2026},
  volume = {0},
  pages = {1--2},
  doi = {10.25259/ijpp_10_2026}
}
Kostenlos starten →